Sigma-2 ligands have been investigated for their therapeutic role in the treatment of cancers, and we have previously shown sigma-2 receptor overexpression in Panc02 tumor bearing C57BL/6 mice and an increased survival in this model by treatment with novel sigma-2 ligands [8,9]. Here, AP2S1 is linked to neoplasm.